ICD (implantable cardioverter defibrillator) trial ends early following positive results
This article was originally published in Clinica
Executive Summary
A major implantable defibrillation clinical trial has been halted early after researchers found that the device reduced the risk of death in heart attack survivors by as much as 30%. The findings strengthen the growing body of evidence pointing to the superiority of the device over drug therapy.